About DEXLEVO
DEXLEVO is a company based in Seoul (South Korea) founded in 2012.. DEXLEVO has raised $21.87 million across 2 funding rounds from investors including Shinhan Financial Group, Smile Gate Investment and Hyundai Venture Investment. DEXLEVO operates in a competitive market with competitors including Incyte, LEO Pharma, Formation Bio, Arcutis and DermBiont, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Dexlevo Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21.87 M (USD)
in 2 rounds
-
Latest Funding Round
$21.87 M (USD), Series B
Nov 25, 2021
-
Investors
Shinhan Financial Group
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of DEXLEVO
DEXLEVO has successfully raised a total of $21.87M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $21.87 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $21.9M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series B - DEXLEVO | Valuation |
investors |
|
| Jun, 2018 | Amount | Series B - DEXLEVO | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DEXLEVO
DEXLEVO has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Shinhan Financial Group, Smile Gate Investment and Hyundai Venture Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm focused on buyouts
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Financial group
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DEXLEVO
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DEXLEVO
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dexlevo Comparisons
Competitors of DEXLEVO
DEXLEVO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, LEO Pharma, Formation Bio, Arcutis and DermBiont, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating dermatology diseases
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
Immunotherapeutic solutions for dermatological conditions are developed.
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dexlevo
Frequently Asked Questions about DEXLEVO
When was DEXLEVO founded?
DEXLEVO was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Where is DEXLEVO located?
DEXLEVO is headquartered in Seoul, South Korea.
Is DEXLEVO a funded company?
DEXLEVO is a funded company, having raised a total of $21.87M across 2 funding rounds to date.
What does DEXLEVO do?
DEXLEVO was founded in 2012 and is based in Seoul, South Korea. Operations focus on the biotechnology sector, where biopolymer-based therapeutics for skin conditions are developed. Key products include Iniblanc, a collagen stimulator used for natural skin collagen regeneration in anti-aging treatments, and DXP01, a volumizing filler. Research and development activities are centered on advancing these dermal applications.
Who are the top competitors of DEXLEVO?
DEXLEVO's top competitors include LEO Pharma, Formation Bio and Arcutis.
Who are DEXLEVO's investors?
DEXLEVO has 4 investors. Key investors include Shinhan Financial Group, Smile Gate Investment, Hyundai Venture Investment, and MAGNA Investment.